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POTENTIAL SMALL ANIMAL MODELS FOR VIRUS-INDUCED
CHRONIC RESPIRATORY DISEASE
Although several clinical studies have suggested that some of the acute
exacerbations of chronic bronchitis may be produced by certain viruses,
the precise role of these agents in the pathogenesis of progressive chronic
respiratory disease has not yet been defined.`8 The prolonged and complex
natural history of chronic respiratory disease in man has made it extremely
difficult to assess the role of viruses in this disease by classical epidemio-
logic methods. The development of a model system for the viral induction
of chronic respiratory disease in the small laboratory animal might eliminate
some of these problems and would provide an experimental basis for assess-
ing the possible role of viral infection in the initiation and progression of
chronic respiratory disease in man.
Since many of the human respiratory viruses such as the adenoviruses,
parainfluenza viruses, respiratory syncytial virus and the rhinoviruses pro-
duce either an inapparent infection or no infection at all in small laboratory
animals, these animals have not been very useful in studies of the patho-
genesis of viral respiratory infections caused by these agents.`7 Influenza
virus, however, will produce an acute upper respiratory infection in the
unanesthetized ferret. If the ferrets are given ether at the time of inocula-
tion, the disease produced will become more severe with serial passage.8
The virus will then become adapted to the lungs and produce an extensive
pneumonia which is often fatal. In addition, influenza virus can be adapted
to produce a lethal pulmonary disease in mice.8' To date, experimental in-
fection of small laboratory animals with these viruses has not been shown to
induce chronic respiratory disease. This accumulated experience suggests
that, with the possible exception of the influenza viruses, it is unlikely that
the direct inoculation of small laboratory animals with human respiratory
viruses will produce a suitable laboratory model of viral chronic respira-
tory disease.
A systematic study of indigenous animal viruses as possible causes of
chronic respiratory disease in small laboratory animals has not been under-
taken. There are many animal viruses that belong to the same virus groups
as the human respiratory viruses and the use of these viruses for the induc-
tion of experimental viral chronic respiratory disease might overcome the
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limited host range of the human respiratory viruses. In addition, the inten-
sive study of natural acute and chronic respiratory disease in small labora-
tory animals might provide additional agents for use in potential animal
model systems.
For many years Nelson at the Rockefeller Institute has been interested
in the etiology of chronic respiratory disease in the laboratory rat."0'l This
disease has been known for many years and the pathology was accurately
described by Hektoen in 1916.' Two main types of lesions were character-
istic. The most common lesion consisted of areas of consolidation with
nodule formation. The nodules correspond microscopically to bronchial
dilation with exudate and fibrosis. The second type of lesion consisted of
gelatinous reddish-gray or light gray areas on the surface of the lungs. These
were associated with mucoid degeneration of exudate and connective tissue
proliferation. The different lesions occurred together in the same lungs
and in the same lobes. The affected rats had few clinical symptoms except
for snuffling and nasal discharge. A recent postmortem study of over 1,200
Wistar albino rats demonstrated the pathologic lesion of chronic bron-
chiectasis in 94 per cent of the animals at 18 months of age.'
The etiology of this disease remained a puzzle for many years. Strepto-
bacillus moniliformis, which was originally thought to be the etiologic agent,
was subsequently proved to be a secondary invader.' In 1937 both Kliene-
berger-Nobel and Nelson isolated mycoplasma from the lungs and bronchial
exudate of affected animals.""l Nelson subsequently designated the specific
chronic respiratory disease associated with mycoplasma as "infectious
catarrh."'
Mycoplasmas could not be recovered, however, from a separate special
colony of rats that had been developed in the 1930's by Nelson even though
these animals continued to show the pathologic lesions of chronic respira-
tory disease. In 1946 Nelson demonstrated that the infectious agent of this
disease, which he designated "enzootic bronchiectasis" or "endemic pneu-
monia," was filterable, transmissable to mice and to special pathogen free
rats, and could not be cultivated on artificial media. The infected mice and
rats regularly showed pneumonitic lesions whereas control animals were
free of pulmonary disease. Subsequently, Nelson demonstrated that this
agent was present naturally in certain other mouse colonies but not in the
animals used in the original transmission studies.
Nelson described this agent as filterable through a Berkefield V filter. It
could not be cultivated in embryonated eggs.' The agent was stable when
stored in dry ice. All attempts to demonstrate bacteria or mycoplasma in
this material either by cultivation on artificial media or by staining failed.
478V FORSYTH
Nelson concluded, therefore, that the etiologic agent of enzootic bron-
chiectasis was a virus.
Joshi, in 1965, reported further studies with the infectious agent of
enzootic bronchiectasis or chronic murine pneumonia.'7 A cytopathic agent
was isolated in rat embryo skin tissue culture incubated for five to six days
at 370C. and then at 25°C. for two days. Using this method, 80 per cent of
the lungs tested yielded a cytopathic agent. The agent was reisolated from
germ-free rats infected with tissue culture material. No agent was isolated
from control animals.
This agent was stable at -20°C., was inactivated at 30-60 minutes at
56°C. and was sensitive to chloroform or acetone. Electron micrographs
showed the agent to be round with a diameter of approximately 110 Ang-
stroms. The agent produced pulmonary lesions after 21 days following
intranasal inoculation of ten day old mice or four week old germ-free rats.
These lesions consisted of peribronchial lymphoid infiltration. Mycoplasma
isolation was sporadic from both normal and affected animals but the
tissue culture isolates were apparently not tested for mycoplasma. Joshi
concluded that this transmissable agent fulfilled Koch's postulates and was
the specific cause of enzootic bronchiectasis or endemic pneumonia. Al-
though Joshi did not isolate any mycoplasma from the lung specimens,
many of the properties of the agent, such as morphology, solvent sensitivity,
and replication in tissue culture with cytopathic effect are also properties
of mycoplasma.
Intensive attempts to propagate Joshi's agent on a variety of media under
various conditions may yet yield a member of the mycoplasma species. If,
however, Joshi's agent is indeed a true virus and is the etiologic agent of
enzootic bronchiectasis in rats, this would provide a suitable animal model
system of viral-induced chronic respiratory disease in a small laboratory
animal.
Two viruses, first isolated from mice in the course of experiments de-
signed to recover possible human respiratory pathogens, are also potential
agents for use in a small animal model system for virus-induced chronic
respiratory disease.
Pneumonia virus of mice (PVM) was first isolated by Horsfall in 1940
in an attempt to recover some of the nonbacterial agents responsible for
human respiratory disease.'8 This agent could be isolated from apparently
normal laboratory mice obtained from several different breeders when the
lung tissues were serially passaged at 7 to 9 day intervals. Pulmonary con-
solidation was noted after the first or second passage and the disease pro-
duced was an interstitial pneumonitis. Although the gross lesions resembled
those produced by influenza virus in mice, they were usually less severe.
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Microscopically, the pneumonitis resembled that produced by influenza
virus. The bronchi and blood vessels were surrounded by dense accumula-
tions of mononuclear cells, the alveolar septa were thickened and contained
exudate, and the alveoli contained fluid with a varying amount of mononu-
clear and red blood cells. The bronchi often contained a polymorphonuclear
exudate. The bronchial epithelium was hyperplastic.
PVM virus is stable at -76° C. but is completely inactivated after 30
minutes at 560 C. It hemagglutinates mouse and hamster erythrocytes, is
sensitive to ether and is thought to be an RNA virus. By Gradacol filtration
the virus appears to have a diameter of 100 to 150 millimicrons.&' Elec-
tron microscopy of PVM particles demonstrates spheres or filaments, 80-
120 mnt in diameter, with an outer spike-covered envelope. It has been
suggested that this virus is a member of a third myxovirus subgroup.'
Subsequent studies of Horsfall and Curnen demonstrated the presence of
neutralizing antibody to this virus in the sera of mice, rabbits, cotton rats,
monkeys, hamsters, and guinea pigs.' Twenty-seven per cent of 165 human
sera had neutralizing antibody to PVM but a survey of paired sera obtained
from patients with a variety of acute respiratory syndromes failed to reveal
any antibody rise to PVM. The ease of isolation of PVM from animals
without apparent disease and the observation that nonspecific substances
such as normal chick-embryo suspension could stimulate the formation of
neutralizing antibody led Horsfall and his colleagues to conclude that
PVM was a latent infection.
Recent experiments by Tennant and co-workers indicate that hemag-
glutination-inhibition (HI) antibody to PVM virus is found only in mice,
hamsters, and rats.' No human HI antibody was detected. In addition, these
workers failed to demonstrate latent virus infection in several mouse
colonies with considerable, little, or no PVM HI antibody. In their studies,
this virus was of low transmissability or infectivity and occurred as an
acute focal enzootic. It is possible that some of the differences noted be-
tween these two groups may be due to strain differences, for these two
investigations are separated by more than 25 years.
Although PVM has been described as a latent infection of mice, there
are no studies of possible chronic infections following the acute disease. In
addition, there have been no long-range studies of the effects of an acute
PVM infection. The available information, however, suggests that PVM in-
fection in mice might prove to be a valuable model system for studying viral
chronic pulmonary disease.
In the early 1950's, Sendai or HVJ virus, a paramyxovirus, was re-
covered in Japan from mice that had been inoculated with lung tissue ob-
tained at autopsy from cases of fatal pneumonia in infants." Later studies
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demonstrated this virus to be indigenous to mice and there is, thus, doubt as
to the human origin of Sendai virus.' Sendai virus, however, is clearly
related serologically to hemadsorption type 2 virus and is classified as
myxovirus parainfluenza type 1.` Antibodies to Sendai virus appear in
human sera following infection with serologically related paramyxoviruses.
Sendai virus has also been isolated from hamsters, swine, and rats.'
In Japan, Sendai virus appeared in mouse colonies as epizootics lasting
3-4 months but the virus could also be recovered easily from apparently
healthy mice.' The virus spread actively between animals and hemag-
glutination-inhibition (HI) antibody appeared to protect the mice against
infection with Sendai virus. In a transmission experiment, all of the day-
old mice infected via the respiratory tract with Sendai virus grown in
tissue culture died within 7 days after inoculation. Cage mate contacts died
within 12 days. Four-week old mice were much less susceptible to the lethal
effect of Sendai virus and 8-week old mice were unaffected clinically by
the virus.
In affected animals, Sendai virus produced an interstitial pneumonia
similar to that seen in mice with influenza virus except that the bronchiolar
involvement was more prominent in the Sendai virus infected animals.'
Tennant has reported another epidemiological pattern of Sendai virus
infection.' When germ-free mice were placed in contact with mice harbor-
ing Sendai virus, an enzootic infection was observed. Virus was first de-
tected at 5 days and by 10 days 80 per cent of the mice yielded virus. By
30 days all the mice had HI antibody and did not shed virus. The infection
was clinically inapparent and the presence of serum antibody was correlated
with the cessation of virus shedding.
Although no latent or chronic Sendai virus infections in mice have been
demonstrated conclusively, this virus-host system has certain attributes
that suggests that it might be developed into a suitable small laboratory
animal model system for virus-induced chronic respiratory disease. First,
Sendai virus is very closely related to hemadsorption type 2 virus (para-
influenza 1 virus) which has been shown to be an important pathogen of
acute respiratory disease in children and possibly to cause some acute
respiratory disease in adults.`' In addition the parainfluenza viruses
have been implicated by some investigators as a cause of acute exacerbations
of chronic bronchitis in man.' Second, the parainfluenza viruses have been
shown to infect man under both natural and artificial circumstances in the
presence of serum antibody.`tm Although recent studies have demonstrated
that nasal antibody will protect against artificial infection with these agents,
there is epidemiologic evidence to suggest that natural reinfection with
these agents occurs during adult life."l"m Third, the parainfluenza viruses
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have been demonstrated to produce a persistent defective infection in certain
tissue culture systems.' Once this persistent infection is established nearly
all of the cells are infected. The yield of infectious virus is usually low and
may be nonexistent. Transmission of the infection takes place at cell divi-
sions without the intervention of extracellular virus but the growth of these
cells is unimpaired. The presence of viral antigens in these cells can be
detected by fluorescent antibody techniques. Sendai virus has been demon-
strated to produce such a defective infection in tissue culture. It is possible
that the failure to detect chronic or latent infections with the parainfluenza
viruses in either experimental animals or man may be related to their ability
to produce a defective infection. If this were to occur in vivo, no infectious
virus would be isolated although continued infection with the defective
virus could play an important role in the pathogenesis of chronic respiratory
disease either through disturbance of cellular physiology or through an
altered or autoimmune response. The Sendai virus-mouse model system
might provide a mechanism for investigating these hypotheses.
All of the agents discussed appear to have promise as potential small
animal model systems for the study of virus-induced chronic respiratory
disease. Much care will be required, however, in the development of such
model systems because of the complex relationships among bacteria, myco-
plasmas, rickettsiae and viruses in these animals. The use of germ-free or
specific pathogen-free animals may be required. On the basis of the data
presented, however, it seems reasonable to undertake the necessary experi-
ments since the development of a small animal mode system for virus-
induced chronic respiratory disease would further our understanding of
the role of viral infections in the initiation and progression of chronic
respiratory disease in man.
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